Discover
LIMN
Liminatus Pharma, Inc.
0.11
1 x 0.11
3 x 0.10
bid
ask
+
0.00
3.99%
2 @ 04:00 PM
0.14 +0.02 (18.82%)
| Ytd | -81.18% | |
| 1y | -98.89% |
0.10
day range
0.12
0.10
52 week range
10.75
| Open | 0.10 | Prev Close | 0.11 | Low | 0.10 | High | 0.12 | Mkt Cap | 5.81M |
| Vol | 22.83M | Avg Vol | 11.67M | EPS | -0.25 | P/E | N/A | Forward P/E | N/A |
| Beta | N/A | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.17 | 200-d Avg | 0.66 | 1yr Est | 0.00 |
LIMN News
benzinga.com
Liminatus Pharma Amends Proposed $320M Merger Deal With InnocsAI As Closing Now Anticipated Before S
Liminatus Pharma, Inc. (Nasdaq: LIMN) ("Liminatus" or the "Company"), a biotechnolog
globenewswire.com
Liminatus Pharma Amends Definitive Merger Agreement with InnocsAI to Expand Oncology Cell Therapy Pi
FULLERTON, Calif., June 30, 2026 (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc. (Nasdaq: LIMN) ("Liminat
benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com
Liminatus Pharma Enters Warrant Exercise Agreement With Existing Investors To Purchase 10,344,000 Sh
In consideration for the immediate exercise of the Existing Warrants for cash, the exercising holder